Literature DB >> 30303737

Impairment of chondrogenesis and microfibrillar network in Adamtsl2 deficiency.

Laure Delhon1, Clémentine Mahaut1, Nicolas Goudin2, Emilie Gaudas1, Kevin Piquand1, Wilfried Le Goff3, Valérie Cormier-Daire1,4, Carine Le Goff1,5.   

Abstract

Mutations in the a disintegrin and metalloproteinase with thrombospondin motif-like 2 ( ADAMTSL2) gene are responsible for the autosomal recessive form of geleophysic dysplasia, which is characterized by short stature, short extremities, and skeletal abnormalities. However, the exact function of ADAMTSL2 is unknown. To elucidate the role of this protein in skeletal development, we generated complementary knockout (KO) mouse models with either total or chondrocyte Adamtsl2 deficiency. We observed that the Adamtsl2 KO mice displayed skeletal abnormalities reminiscent of the human phenotype. Adamtsl2 deletion affected the growth plate formation with abnormal differentiation and proliferation of chondrocytes. In addition, a TGF-β signaling impairment in limbs lacking Adamtsl2 was demonstrated. Further investigations revealed that Adamtsl2 KO chondrocytes failed to establish a microfibrillar network composed by fibrillin1 and latent TGF-β binding protein 1 fibrils. Chondrocyte Adamtsl2 KO mice also exhibited dwarfism. These studies uncover the function of Adamtsl2 in the maintenance of the growth plate ECM by modulating the microfibrillar network.-Delhon, L., Mahaut, C., Goudin, N., Gaudas, E., Piquand, K., Le Goff, W., Cormier-Daire, V., Le Goff, C. Impairment of chondrogenesis and microfibrillar network in Adamtsl2 deficiency.

Entities:  

Keywords:  cartilage; extracellular matrix; geleophysic dysplasia; mouse model

Mesh:

Substances:

Year:  2018        PMID: 30303737     DOI: 10.1096/fj.201800753RR

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  12 in total

1.  Limb- and tendon-specific Adamtsl2 deletion identifies a role for ADAMTSL2 in tendon growth in a mouse model for geleophysic dysplasia.

Authors:  Dirk Hubmacher; Nandaraj Taye; Zerina Balic; Stetson Thacker; Sheila M Adams; David E Birk; Ronen Schweitzer; Suneel S Apte
Journal:  Matrix Biol       Date:  2019-02-07       Impact factor: 11.583

2.  ADAMTS9 and ADAMTS20 are differentially affected by loss of B3GLCT in mouse model of Peters plus syndrome.

Authors:  Bernadette C Holdener; Christopher J Percival; Richard C Grady; Daniel C Cameron; Steven J Berardinelli; Ao Zhang; Sanjiv Neupane; Megumi Takeuchi; Javier C Jimenez-Vega; Sardar M Z Uddin; David E Komatsu; Robert Honkanen; Johanne Dubail; Suneel S Apte; Takashi Sato; Hisashi Narimatsu; Steve A McClain; Robert S Haltiwanger
Journal:  Hum Mol Genet       Date:  2019-12-15       Impact factor: 6.150

3.  Candesartan prevents arteriopathy progression in cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy model.

Authors:  Taisuke Kato; Ri-Ichiroh Manabe; Hironaka Igarashi; Fuyuki Kametani; Sachiko Hirokawa; Yumi Sekine; Natsumi Fujita; Satoshi Saito; Yusuke Kawashima; Yuya Hatano; Shoichiro Ando; Hiroaki Nozaki; Akihiro Sugai; Masahiro Uemura; Masaki Fukunaga; Toshiya Sato; Akihide Koyama; Rie Saito; Atsushi Sugie; Yasuko Toyoshima; Hirotoshi Kawata; Shigeo Murayama; Masaki Matsumoto; Akiyoshi Kakita; Masato Hasegawa; Masafumi Ihara; Masato Kanazawa; Masatoyo Nishizawa; Shoji Tsuji; Osamu Onodera
Journal:  J Clin Invest       Date:  2021-11-15       Impact factor: 14.808

4.  O-Fucosylation of ADAMTSL2 is required for secretion and is impacted by geleophysic dysplasia-causing mutations.

Authors:  Ao Zhang; Steven J Berardinelli; Christina Leonhard-Melief; Deepika Vasudevan; Ta-Wei Liu; Andrew Taibi; Sharee Giannone; Suneel S Apte; Bernadette C Holdener; Robert S Haltiwanger
Journal:  J Biol Chem       Date:  2020-09-10       Impact factor: 5.157

5.  The extracellular matrix glycoprotein ADAMTSL2 is increased in heart failure and inhibits TGFβ signalling in cardiac fibroblasts.

Authors:  Karoline B Rypdal; Pugazendhi M Erusappan; A Olav Melleby; Deborah E Seifert; Sheryl Palmero; Mari E Strand; Theis Tønnessen; Christen P Dahl; Vibeke Almaas; Dirk Hubmacher; Suneel S Apte; Geir Christensen; Ida G Lunde
Journal:  Sci Rep       Date:  2021-10-05       Impact factor: 4.379

Review 6.  Cooperative Mechanism of ADAMTS/ ADAMTSL and Fibrillin-1 in the Marfan Syndrome and Acromelic Dysplasias.

Authors:  Pauline Arnaud; Zakaria Mougin; Catherine Boileau; Carine Le Goff
Journal:  Front Genet       Date:  2021-11-29       Impact factor: 4.599

7.  The potential prognostic values of the ADAMTS-like protein family: an integrative pan-cancer analysis.

Authors:  Xiaoyue Zhang; Wendi Yang; Kehong Chen; Taihao Zheng; Zhengjun Guo; Yuan Peng; Zhenzhou Yang
Journal:  Ann Transl Med       Date:  2021-10

8.  Acromelic dysplasias: how rare musculoskeletal disorders reveal biological functions of extracellular matrix proteins.

Authors:  Sarah Stanley; Zerina Balic; Dirk Hubmacher
Journal:  Ann N Y Acad Sci       Date:  2020-09-02       Impact factor: 5.691

Review 9.  ADAMTS Proteins and Vascular Remodeling in Aortic Aneurysms.

Authors:  Zakaria Mougin; Julia Huguet Herrero; Catherine Boileau; Carine Le Goff
Journal:  Biomolecules       Date:  2021-12-22

Review 10.  The quest for substrates and binding partners: A critical barrier for understanding the role of ADAMTS proteases in musculoskeletal development and disease.

Authors:  Brandon Satz-Jacobowitz; Dirk Hubmacher
Journal:  Dev Dyn       Date:  2020-09-17       Impact factor: 3.780

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.